ARROWHEAD PHARMACEUTICALS IN (ARWR) Stock Earnings & Estimates
USA - NASDAQ:ARWR - US04280A1007 - Common Stock
37.85 USD
-1.76 (-4.44%)
37.97 USD
+0.12 (+0.32%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 243.2M 75.85% | 240.7M -1.03% | 3.551M -98.52% | 759.46M 21,287.21% | 398.73M -47.50% | 338.51M -15.10% | 429.59M 26.91% | 793M 84.59% | 1.463B 84.49% | 2.224B 52.02% | 2.876B 29.32% | |
| EBITDA YoY % growth | -168.1M -19.47% | -192.5M -14.52% | -582.485M -202.59% | 82.763M 114.21% | -358.77M -533.49% | -533.076M -48.58% | -499.29M 6.34% | -226.644M 54.61% | 515.61M 327.50% | N/A | N/A | |
| EBIT YoY % growth | -178.5M -19.80% | -205M -14.85% | -601.08M -193.21% | 59.146M 109.84% | -359.738M -708.22% | -452.751M -25.86% | -382.874M 15.43% | -80.852M 78.88% | 536.91M 764.07% | 1.128B 110.09% | 1.672B 48.23% | |
| Operating Margin | -73.40% | -85.17% | -16,927.06% | 7.79% | -90.22% | -133.75% | -89.13% | -10.20% | 36.70% | 50.72% | 58.14% | |
| EPS YoY % growth | -1.68 -23.53% | -1.92 -14.29% | -5.01 -160.94% | 0.08 101.51% | -2.92 -3,958.10% | -3.17 -8.64% | -2.59 18.33% | -0.10 96.25% | 5.09 5,350.00% | 9.35 83.86% | 13.35 42.71% |
All data in USD
| Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.21 84.37% | 0.35 125.07% | -0.92 -133.31% | -1.26 -0.06% | -1.03 -382.35% |
| Revenue Q2Q % growth | 203.7M | 294.34M 11,673.60% | 78.767M -85.49% | 36.092M 29.98% | 54.58M -73.21% |
| EBITDA Q2Q % growth | 13.893M 109.67% | 24.689M 115.81% | N/A | N/A | N/A |
| EBIT Q2Q % growth | -17.799M 89.03% | 45.032M 127.90% | -151.356M -139.70% | -163.061M 1.50% | -162.801M -814.66% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | -1.26 8.70% | -1.05 | -0.21 | -20.51% |
| Q2 2025 Q2Q % growth | 2.75 369.61% | -0.20 | 2.95 | 1,461.66% |
| Q1 2025 Q2Q % growth | -1.39 -12.10% | -0.45 | -0.94 | -211.36% |
| Q4 2024 Q2Q % growth | -1.37 -34.31% | -1.07 | -0.30 | -28.19% |
| Q3 2024 Q2Q % growth | -1.38 -43.75% | -0.56 | -0.82 | -145.24% |
| Q2 2024 Q2Q % growth | -1.02 -326.67% | -0.17 | -0.85 | -515.69% |
| Q1 2024 Q2Q % growth | -1.24 -217.95% | -0.84 | -0.40 | -48.25% |
| Q4 2023 Q2Q % growth | -1.02 -25.93% | -0.62 | -0.40 | -65.77% |
| Q3 2023 Q2Q % growth | -0.96 -41.18% | -0.67 | -0.29 | -44.13% |
| Q2 2023 Q2Q % growth | 0.45 9.76% | -0.65 | 1.10 | 168.84% |
| Q1 2023 Q2Q % growth | -0.39 35.00% | 0.45 | -0.84 | -187.62% |
| Q4 2022 Q2Q % growth | -0.81 -32.79% | -0.17 | -0.64 | -379.95% |
| Q3 2022 Q2Q % growth | -0.68 -134.48% | -0.52 | -0.16 | -31.80% |
| Q2 2022 Q2Q % growth | 0.41 257.69% | -0.08 | 0.49 | 596.25% |
| Q1 2022 Q2Q % growth | -0.60 -200.00% | -0.46 | -0.14 | -31.60% |
| Q4 2021 Q2Q % growth | -0.61 -27.08% | -0.11 | -0.50 | -467.08% |
| Q3 2021 Q2Q % growth | -0.29 -123.08% | -0.20 | -0.09 | -44.10% |
| Q2 2021 Q2Q % growth | -0.26 -30.00% | -0.13 | -0.13 | -94.14% |
| Q1 2021 Q2Q % growth | -0.20 -566.67% | 0.12 | -0.32 | -266.32% |
| Q4 2020 Q2Q % growth | -0.48 -536.36% | 0.12 | -0.60 | -504.42% |
| Q3 2020 Q2Q % growth | -0.13 -161.90% | -0.12 | -0.01 | -9.87% |
| Q2 2020 Q2Q % growth | -0.20 -183.33% | -0.11 | -0.09 | -80.07% |
| Q1 2020 Q2Q % growth | -0.03 -123.08% | -0.01 | -0.02 | -311.93% |
| Q4 2019 Q2Q % growth | 0.11 | 0.17 | -0.06 | -34.36% |
| Q3 2019 Q2Q % growth | 0.21 | 0.30 | -0.09 | -29.81% |
| Q2 2019 Q2Q % growth | 0.24 | 0.20 | 0.04 | 21.71% |
| Q1 2019 Q2Q % growth | 0.13 | 0.55 | -0.42 | -76.32% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | 27.767M | 24.185M | 3.582M | 14.81% |
| Q2 2025 Q2Q % growth | 543M | 30.504M | 512.496M | 1,680.09% |
| Q1 2025 Q2Q % growth | 2.5M -29.60% | 74.205M | -71.705M | -96.63% |
| Q4 2024 Q2Q % growth | -100.00% | 65.099M | -65.099M | -100.00% |
| Q3 2024 Q2Q % growth | -100.00% | 53.688M | -53.688M | -100.00% |
| Q2 2024 Q2Q % growth | -100.00% | 65.147M | -65.147M | -100.00% |
| Q1 2024 Q2Q % growth | 3.551M -94.32% | 30.101M | -26.55M | -88.20% |
| Q4 2023 Q2Q % growth | 16.097M -49.06% | 51.743M | -35.646M | -68.89% |
| Q3 2023 Q2Q % growth | 15.825M -51.16% | 50.169M | -34.344M | -68.46% |
| Q2 2023 Q2Q % growth | 146.267M -3.64% | 46.389M | 99.878M | 215.31% |
| Q1 2023 Q2Q % growth | 62.5M 128.10% | 165.77M | -103.27M | -62.30% |
| Q4 2022 Q2Q % growth | 31.6M -17.49% | 51.453M | -19.853M | -38.58% |
| Q3 2022 Q2Q % growth | 32.4M -29.41% | 56.332M | -23.932M | -42.48% |
| Q2 2022 Q2Q % growth | 151.8M 362.80% | 111.09M | 40.71M | 36.65% |
| Q1 2022 Q2Q % growth | 27.4M 28.64% | 52.065M | -24.665M | -47.37% |
| Q4 2021 Q2Q % growth | 38.3M 403.95% | 57.91M | -19.61M | -33.86% |
| Q3 2021 Q2Q % growth | 45.9M 67.52% | 38.267M | 7.633M | 19.95% |
| Q2 2021 Q2Q % growth | 32.8M 39.57% | 38.451M | -5.651M | -14.70% |
| Q1 2021 Q2Q % growth | 21.3M -27.80% | 77.076M | -55.776M | -72.36% |
| Q4 2020 Q2Q % growth | 7.6M -82.45% | 50.227M | -42.627M | -84.87% |
| Q3 2020 Q2Q % growth | 27.4M -35.83% | 29.49M | -2.09M | -7.09% |
| Q2 2020 Q2Q % growth | 23.5M -51.14% | 22.175M | 1.325M | 5.98% |
| Q1 2020 Q2Q % growth | 29.5M -14.99% | 30.09M | -590K | -1.96% |
| Q4 2019 Q2Q % growth | 43.3M | 42.311M | 989K | 2.34% |
| Q3 2019 Q2Q % growth | 42.7M | 55.454M | -12.754M | -23.00% |
| Q2 2019 Q2Q % growth | 48.1M | 43.848M | 4.252M | 9.70% |
| Q1 2019 Q2Q % growth | 34.7M | 73.032M | -38.332M | -52.49% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -20.58% | 44.31% | -39.39% | 78.68% |
| Revenue | -1.72% | -4.24% | -0.62% | -4.88% |